{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:50:40Z","timestamp":1758970240569,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DA 2255\/1-1"],"award-info":[{"award-number":["DA 2255\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes is by far, the most common cause of neuropathy, inducing neurodegeneration of terminal sensory nerve fibers associated with loss of sensation, paresthesia, and persistent pain. Foretinib prevents die-back degeneration in cultured sensory and sympathetic neurons by rescuing mitochondrial activity and has been proven safe in prospective clinical trials. Here we aimed at investigating a potential neuroprotective effect of Foretinib in experimental diabetic neuropathy. A mouse model of streptozotocin induced diabetes was used that expresses yellow fluorescent protein (YFP) in peripheral nerve fibers under the thy-1 promoter. Streptozotocin-injected mice developed a stable diabetic state (blood glucose\u2009&gt;\u2009270\u00a0mg\/dl), with a significant reduction of intraepidermal nerve fiber density by 25% at 5\u00a0weeks compared to the non-diabetic controls. When diabetic mice were treated with Foretinib, a significantly greater volume of the cutaneous nerve fibers (67.3%) in the plantar skin was preserved compared to vehicle treated (37.8%) and non-treated (44.9%) diabetic mice while proximal nerve fiber morphology was not affected. Our results indicate a neuroprotective effect of Foretinib on cutaneous nerve fibers in experimental diabetic neuropathy. As Foretinib treated mice showed greater weight loss compared to vehicle treated controls, future studies may define more sustainable treatment regimen and thereby may allow patients to take advantage of this neuroprotective drug in chronic neurodegenerative diseases like diabetic neuropathy.<\/jats:p>","DOI":"10.1038\/s41598-022-12455-3","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T11:25:02Z","timestamp":1652959502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Foretinib mitigates cutaneous nerve fiber loss in experimental diabetic neuropathy"],"prefix":"10.1038","volume":"12","author":[{"given":"Simeon C.","family":"Daeschler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory H.","family":"Borschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"12455_CR1","unstructured":"Federation., I. D. (brussels, belgium, 2019)."},{"key":"12455_CR2","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2337\/diab.38.11.1456","volume":"38","author":"RE Maser","year":"1989","unstructured":"Maser, R. E. et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study. Diabetes 38, 1456\u20131461. https:\/\/doi.org\/10.2337\/diab.38.11.1456 (1989).","journal-title":"Diabetes"},{"key":"12455_CR3","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.2337\/db13-1819","volume":"63","author":"D Ziegler","year":"2014","unstructured":"Ziegler, D. et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 63, 2454\u20132463. https:\/\/doi.org\/10.2337\/db13-1819 (2014).","journal-title":"Diabetes"},{"key":"12455_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1530\/joe-16-0284","volume":"231","author":"J Leckelt","year":"2016","unstructured":"Leckelt, J. et al. Early detection of diabetic neuropathy by investigating CNFL and IENFD in thy1-YFP mice. J. Endocrinol. 231, 147\u2013157. https:\/\/doi.org\/10.1530\/joe-16-0284 (2016).","journal-title":"J. Endocrinol."},{"key":"12455_CR5","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.2337\/dc11-1108","volume":"34","author":"CA Abbott","year":"2011","unstructured":"Abbott, C. A., Malik, R. A., van Ross, E. R., Kulkarni, J. & Boulton, A. J. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 34, 2220\u20132224. https:\/\/doi.org\/10.2337\/dc11-1108 (2011).","journal-title":"Diabetes Care"},{"key":"12455_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00131402-200112000-00001","volume":"3","author":"L Johannsen","year":"2001","unstructured":"Johannsen, L. et al. Evaluation of patients with symptoms suggestive of chronic polyneuropathy. J. Clin. Neuromuscul. Dis. 3, 47\u201352 (2001).","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"12455_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/wnl.43.4.817","volume":"43","author":"PJ Dyck","year":"1993","unstructured":"Dyck, P. J. et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester diabetic neuropathy study. Neurology 43, 817\u2013824. https:\/\/doi.org\/10.1212\/wnl.43.4.817 (1993).","journal-title":"Neurology"},{"key":"12455_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","volume":"49","author":"P Zhang","year":"2017","unstructured":"Zhang, P. et al. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis (\u2020). Ann. Med. 49, 106\u2013116. https:\/\/doi.org\/10.1080\/07853890.2016.1231932 (2017).","journal-title":"Ann. Med."},{"key":"12455_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/bjd.15254","volume":"176","author":"S Schreml","year":"2017","unstructured":"Schreml, S. & Berneburg, M. The global burden of diabetic wounds. Br. J. Dermatol. 176, 845\u2013846. https:\/\/doi.org\/10.1111\/bjd.15254 (2017).","journal-title":"Br. J. Dermatol."},{"key":"12455_CR10","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1001\/jama.2015.13611","volume":"314","author":"BC Callaghan","year":"2015","unstructured":"Callaghan, B. C., Price, R. S. & Feldman, E. L. Distal symmetric polyneuropathy: A review. JAMA 314, 2172\u20132181. https:\/\/doi.org\/10.1001\/jama.2015.13611 (2015).","journal-title":"JAMA"},{"issue":"Pt 11","key":"12455_CR11","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/brain\/122.11.2109","volume":"122","author":"JN Scott","year":"1999","unstructured":"Scott, J. N., Clark, A. W. & Zochodne, D. W. Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain 122(Pt 11), 2109\u20132118. https:\/\/doi.org\/10.1093\/brain\/122.11.2109 (1999).","journal-title":"Brain"},{"key":"12455_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","volume":"13","author":"NP Goncalves","year":"2017","unstructured":"Goncalves, N. P. et al. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat. Rev. Neurol. 13, 135\u2013147. https:\/\/doi.org\/10.1038\/nrneurol.2016.201 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"12455_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.mcn.2007.10.004","volume":"37","author":"LF Gumy","year":"2008","unstructured":"Gumy, L. F., Bampton, E. T. & Tolkovsky, A. M. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol. Cell Neurosci. 37, 298\u2013311. https:\/\/doi.org\/10.1016\/j.mcn.2007.10.004 (2008).","journal-title":"Mol. Cell Neurosci."},{"key":"12455_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nbd.2012.03.016","volume":"51","author":"SK Chowdhury","year":"2013","unstructured":"Chowdhury, S. K., Smith, D. R. & Fernyhough, P. The role of aberrant mitochondrial bioenergetics in diabetic neuropathy. Neurobiol. Dis. 51, 56\u201365. https:\/\/doi.org\/10.1016\/j.nbd.2012.03.016 (2013).","journal-title":"Neurobiol. Dis."},{"key":"12455_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2017.00012","volume":"8","author":"K Sango","year":"2017","unstructured":"Sango, K., Mizukami, H., Horie, H. & Yagihashi, S. Impaired axonal regeneration in diabetes. Perspective on the underlying mechanism from in vivo and in vitro experimental studies. Front. Endocrinol. 8, 12. https:\/\/doi.org\/10.3389\/fendo.2017.00012 (2017).","journal-title":"Front. Endocrinol."},{"key":"12455_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/bmj.39213.565972.AE","volume":"335","author":"MC Wong","year":"2007","unstructured":"Wong, M. C., Chung, J. W. & Wong, T. K. Effects of treatments for symptoms of painful diabetic neuropathy: Systematic review. BMJ 335, 87. https:\/\/doi.org\/10.1136\/bmj.39213.565972.AE (2007).","journal-title":"BMJ"},{"key":"12455_CR17","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1083\/jcb.201705085","volume":"216","author":"K Feinberg","year":"2017","unstructured":"Feinberg, K. et al. A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria. J. Cell Biol. 216, 3655\u20133675. https:\/\/doi.org\/10.1083\/jcb.201705085 (2017).","journal-title":"J. Cell Biol."},{"key":"12455_CR18","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1158\/1078-0432.ccr-16-1789","volume":"23","author":"TCC Yau","year":"2017","unstructured":"Yau, T. C. C. et al. A phase I\/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma. Clin. Cancer Res. 23, 2405\u20132413. https:\/\/doi.org\/10.1158\/1078-0432.ccr-16-1789 (2017).","journal-title":"Clin. Cancer Res."},{"key":"12455_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10637-012-9861-3","volume":"31","author":"T Seiwert","year":"2013","unstructured":"Seiwert, T. et al. Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Invest. New Drugs 31, 417\u2013424. https:\/\/doi.org\/10.1007\/s10637-012-9861-3 (2013).","journal-title":"Invest. New Drugs"},{"key":"12455_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1200\/jco.2012.43.3383","volume":"31","author":"TK Choueiri","year":"2013","unstructured":"Choueiri, T. K. et al. Phase II and biomarker study of the dual MET\/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J. Clin. Oncol. 31, 181\u2013186. https:\/\/doi.org\/10.1200\/jco.2012.43.3383 (2013).","journal-title":"J. Clin. Oncol."},{"key":"12455_CR21","doi-asserted-by":"publisher","first-page":"3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 20. PLOS Biol. 18, 3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"PLOS Biol."},{"key":"12455_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cpmo.11","volume":"6","author":"CG Jolivalt","year":"2016","unstructured":"Jolivalt, C. G. et al. Phenotyping peripheral neuropathy in mouse models of diabetes. Curr. Protoc. Mouse Biol. 6, 223\u2013255. https:\/\/doi.org\/10.1002\/cpmo.11 (2016).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"12455_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","volume":"12","author":"G Lauria","year":"2005","unstructured":"Lauria, G. et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol. 12, 747\u2013758. https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01260.x (2005).","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"12455_CR24","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.4103\/1673-5374.329473","volume":"17","author":"C Daeschler, Simeon","year":"2022","unstructured":"Daeschler, Simeon, C. et al. Optical tissue clearing enables rapid, precise and comprehensive assessment of three-dimensional morphology in experimental nerve regeneration research. Neural Regen. Res. 17(6), 1348\u20131356. https:\/\/doi.org\/10.4103\/1673-5374.329473 (2022).","journal-title":"Neural Regen. Res."},{"key":"12455_CR25","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.1126\/sciadv.aau8355","volume":"5","author":"Y Qi","year":"2019","unstructured":"Qi, Y. et al. FDISCO: Advanced solvent-based clearing method for imaging whole organs. Sci. Adv. 5, 8355. https:\/\/doi.org\/10.1126\/sciadv.aau8355 (2019).","journal-title":"Sci. Adv."},{"key":"12455_CR26","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1038\/s41598-022-10066-6","volume":"12","author":"C Daeschler, Simeon","year":"2022","unstructured":"Daeschler, S. C. et al. Rapid, automated nerve histomorphometry through open-source artificial intelligence. Sci Rep. 12, 5975. https:\/\/doi.org\/10.1038\/s41598-022-10066-6 (2022).","journal-title":"Sci Rep."},{"key":"12455_CR27","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41598-018-22181-4","volume":"8","author":"A Zaimi","year":"2018","unstructured":"Zaimi, A. et al. AxonDeepSeg: Automatic axon and myelin segmentation from microscopy data using convolutional neural networks. Sci. Rep. 8, 3816. https:\/\/doi.org\/10.1038\/s41598-018-22181-4 (2018).","journal-title":"Sci. Rep."},{"key":"12455_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/b978-0-444-53480-4.00016-3","volume":"126","author":"RA Malik","year":"2014","unstructured":"Malik, R. A. Pathology of human diabetic neuropathy. Handb. Clin. Neurol. 126, 249\u2013259. https:\/\/doi.org\/10.1016\/b978-0-444-53480-4.00016-3 (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"12455_CR29","doi-asserted-by":"publisher","first-page":"14940","DOI":"10.18632\/oncotarget.3613","volume":"6","author":"HM Chen","year":"2015","unstructured":"Chen, H. M., Tsai, C. H. & Hung, W. C. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2\/3 and TIE-2 signaling. Oncotarget 6, 14940\u201314952. https:\/\/doi.org\/10.18632\/oncotarget.3613 (2015).","journal-title":"Oncotarget"},{"key":"12455_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/0023677217747915","volume":"52","author":"SA N\u00f8rgaard","year":"2018","unstructured":"N\u00f8rgaard, S. A., Sand, F. W., S\u00f8rensen, D. B., Abelson, K. S. & S\u00f8ndergaard, H. Softened food reduces weight loss in the streptozotocin-induced male mouse model of diabetic nephropathy. Lab. Anim. 52, 373\u2013383. https:\/\/doi.org\/10.1177\/0023677217747915 (2018).","journal-title":"Lab. Anim."},{"key":"12455_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jns5.12072","volume":"19","author":"GJ Biessels","year":"2014","unstructured":"Biessels, G. J. et al. Phenotyping animal models of diabetic neuropathy: A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J. Periph. Nerv. Syst. JPNS 19, 77\u201387. https:\/\/doi.org\/10.1111\/jns5.12072 (2014).","journal-title":"J. Periph. Nerv. Syst. JPNS"},{"key":"12455_CR32","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1016\/j.ajpath.2014.06.016","volume":"184","author":"D Cai","year":"2014","unstructured":"Cai, D., Zhu, M., Petroll, W. M., Koppaka, V. & Robertson, D. M. The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am. J. Pathol. 184, 2662\u20132670. https:\/\/doi.org\/10.1016\/j.ajpath.2014.06.016 (2014).","journal-title":"Am. J. Pathol."},{"key":"12455_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.nbd.2007.07.022","volume":"28","author":"KA Sullivan","year":"2007","unstructured":"Sullivan, K. A. et al. Mouse models of diabetic neuropathy. Neurobiol. Dis. 28, 276\u2013285. https:\/\/doi.org\/10.1016\/j.nbd.2007.07.022 (2007).","journal-title":"Neurobiol. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12455-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:25:13Z","timestamp":1669346713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12455-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12455-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8444"}}